0 XP   0   0   0

Opko Health Inc










Financial Health of Opko




Comparing to competitors in the Diagnostics & Research industry




  Industry Rankings  


Opko Health Inc
Buy, Hold or Sell?

Should you buy, hold or sell Opko?

I guess you are interested in Opko Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Opko

Let's start. I'm going to help you getting a better view of Opko Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Opko Health Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Opko Health Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Opko Health Inc. The closing price on 2022-12-05 was ILA500.50 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Opko Health Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Opko Health Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Opko earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Opko Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-17.0%+17.0%
TTM-17.0%YOY4.0%-21.0%
TTM-17.0%5Y-3.2%-13.8%
5Y-3.2%10Y-3.3%+0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--7.3%+7.3%
TTM-17.0%-4.9%-12.1%
YOY4.0%0.5%+3.5%
5Y-3.2%-5.8%+2.6%
10Y-3.3%-3.4%+0.1%
1.1.2. Return on Assets

Shows how efficient Opko is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • -3.6% Return on Assets means that Opko generated -0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Opko Health Inc:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-3.4%-0.3%
TTM-3.4%YOY0.8%-4.1%
TTM-3.4%5Y-0.5%-2.8%
5Y-0.5%10Y-0.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-0.5%-3.1%
TTM-3.4%-0.4%-3.0%
YOY0.8%0.2%+0.6%
5Y-0.5%-0.8%+0.3%
10Y-0.5%-0.8%+0.3%
1.1.3. Return on Equity

Shows how efficient Opko is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • -5.0% Return on Equity means Opko generated -0.05 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Opko Health Inc:

  • The MRQ is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.0%TTM-4.7%-0.3%
TTM-4.7%YOY1.1%-5.8%
TTM-4.7%5Y-0.7%-4.0%
5Y-0.7%10Y-0.7%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.0%0.7%-5.7%
TTM-4.7%0.3%-5.0%
YOY1.1%0.6%+0.5%
5Y-0.7%-1.3%+0.6%
10Y-0.7%-1.8%+1.1%

1.2. Operating Efficiency of Opko Health Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Opko is operating .

  • Measures how much profit Opko makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Opko Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11.5%+11.5%
TTM-11.5%YOY4.6%-16.2%
TTM-11.5%5Y-0.7%-10.8%
5Y-0.7%10Y-1.7%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-0.3%
TTM-11.5%-1.8%-9.7%
YOY4.6%1.1%+3.5%
5Y-0.7%-2.5%+1.8%
10Y-1.7%-1.6%-0.1%
1.2.2. Operating Ratio

Measures how efficient Opko is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Opko Health Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.390-1.390
TTM1.390YOY1.605-0.215
TTM1.3905Y0.843+0.546
5Y0.84310Y0.749+0.095
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.329-1.329
TTM1.3901.234+0.156
YOY1.6051.234+0.371
5Y0.8431.103-0.260
10Y0.7491.031-0.282

1.3. Liquidity of Opko Health Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Opko is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.55 means the company has 1.55 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Opko Health Inc:

  • The MRQ is 1.549. The company is able to pay all its short-term debts. +1
  • The TTM is 2.195. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.549TTM2.195-0.645
TTM2.195YOY1.661+0.533
TTM2.1955Y1.455+0.739
5Y1.45510Y1.500-0.045
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5492.412-0.863
TTM2.1952.617-0.422
YOY1.6612.767-1.106
5Y1.4552.626-1.171
10Y1.5002.837-1.337
1.3.2. Quick Ratio

Measures if Opko is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off 0.00 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Opko Health Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.583-0.583
TTM0.583YOY0.867-0.284
TTM0.5835Y0.646-0.063
5Y0.64610Y0.695-0.048
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.321-1.321
TTM0.5831.454-0.871
YOY0.8671.515-0.648
5Y0.6461.553-0.907
10Y0.6951.530-0.835

1.4. Solvency of Opko Health Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Opko assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opko to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.27 means that Opko assets are financed with 27.5% credit (debt) and the remaining percentage (100% - 27.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Opko Health Inc:

  • The MRQ is 0.275. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.287-0.012
TTM0.287YOY0.300-0.013
TTM0.2875Y0.295-0.009
5Y0.29510Y0.286+0.010
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.404-0.129
TTM0.2870.404-0.117
YOY0.3000.433-0.133
5Y0.2950.453-0.158
10Y0.2860.442-0.156
1.4.2. Debt to Equity Ratio

Measures if Opko is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 37.9% means that company has 0.38 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Opko Health Inc:

  • The MRQ is 0.379. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.402. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.402-0.024
TTM0.402YOY0.431-0.028
TTM0.4025Y0.420-0.018
5Y0.42010Y0.402+0.018
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.598-0.219
TTM0.4020.620-0.218
YOY0.4310.672-0.241
5Y0.4200.753-0.333
10Y0.4020.741-0.339

2. Market Valuation of Opko Health Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Opko generates.

  • Above 15 is considered overpriced but always compare Opko to the Diagnostics & Research industry mean.
  • A PE ratio of -5,929.31 means the investor is paying -5,929.31 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Opko Health Inc:

  • The EOD is -4,491.630. Company is losing money. -2
  • The MRQ is -5,929.311. Company is losing money. -2
  • The TTM is -11,045.464. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-4,491.630MRQ-5,929.311+1,437.681
MRQ-5,929.311TTM-11,045.464+5,116.153
TTM-11,045.464YOY9,125.573-20,171.037
TTM-11,045.4645Y2,599.469-13,644.933
5Y2,599.46910Y-11,273.242+13,872.712
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4,491.630-1.994-4,489.636
MRQ-5,929.311-2.312-5,926.999
TTM-11,045.464-4.930-11,040.534
YOY9,125.573-0.548+9,126.121
5Y2,599.469-1.611+2,601.080
10Y-11,273.242-1.973-11,271.269
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Opko.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Opko Health Inc:

  • The MRQ is -32,830.460. Very Bad. -2
  • The TTM is -13,322.568. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-32,830.460TTM-13,322.568-19,507.892
TTM-13,322.568YOY-187,124.893+173,802.325
TTM-13,322.5685Y-80,377.649+67,055.081
5Y-80,377.64910Y-62,788.658-17,588.991
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-32,830.460-0.052-32,830.408
TTM-13,322.5680.036-13,322.604
YOY-187,124.8930.113-187,125.006
5Y-80,377.6490.023-80,377.672
10Y-62,788.6580.023-62,788.681

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Opko is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 297.02 means the investor is paying 297.02 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Opko Health Inc:

  • The EOD is 225.000. Seems overpriced? -1
  • The MRQ is 297.018. Seems overpriced? -1
  • The TTM is 481.872. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD225.000MRQ297.018-72.018
MRQ297.018TTM481.872-184.854
TTM481.872YOY583.112-101.240
TTM481.8725Y497.536-15.664
5Y497.53610Y600.698-103.162
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD225.0002.021+222.979
MRQ297.0182.205+294.813
TTM481.8723.188+478.684
YOY583.1124.346+578.766
5Y497.5363.414+494.122
10Y600.6983.056+597.642
2. Total Gains per Share

2.4. Latest News of Opko Health Inc

Does Opko Health Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Opko Health Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-29
16:47
Here's Why You Should Hold OPKO Health (OPK) Stock For NowRead
2022-11-16
11:08
Phillip Frost Is The Chairman & CEO of OPKO Health, Inc. (NASDAQ:OPK) And Just Spent US$319k On SharesRead
2022-11-09
14:39
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues TopRead
2022-11-08
23:35
OPKO Health (OPK) Reports Q3 Loss, Tops Revenue EstimatesRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Opko Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0150%0.046-100%-0.0240%0.093-100%
Book Value Growth----0.0080%0.021-100%-0.0100%-0.0090%
Book Value Per Share--2.2242.180+2%2.2250%2.213+1%2.297-3%
Book Value Per Share Growth----0.0080%0.021-100%-0.0100%-0.0090%
Current Ratio--1.5492.195-29%1.661-7%1.455+6%1.500+3%
Debt To Asset Ratio--0.2750.287-4%0.300-9%0.295-7%0.286-4%
Debt To Equity Ratio--0.3790.402-6%0.431-12%0.420-10%0.402-6%
Dividend Per Share----0%-0%-0%-0%
Eps---0.111-0.103-8%0.025-554%-0.016-86%-0.015-86%
Eps Growth--0.181-0.333+284%-0.283+256%-0.103+157%-0.141+178%
Gross Profit Margin--1.0001.0000%1.0000%0.550+82%0.542+85%
Net Profit Margin----0.1700%0.040-100%-0.0320%-0.0330%
Operating Margin----0.1150%0.046-100%-0.0070%-0.0170%
Operating Ratio---1.390-100%1.605-100%0.843-100%0.749-100%
Pb Ratio225.000-32%297.018481.872-38%583.112-49%497.536-40%600.698-51%
Pe Ratio-4491.630+24%-5929.311-11045.464+86%9125.573-165%2599.469-328%-11273.242+90%
Peg Ratio---32830.460-13322.568-59%-187124.893+470%-80377.649+145%-62788.658+91%
Price Per Share500.500-32%660.7001046.350-37%1295.500-49%1107.840-40%1428.408-54%
Profit Growth--18.060-33.304+284%-28.261+256%-10.265+157%-14.070+178%
Quick Ratio---0.583-100%0.867-100%0.646-100%0.695-100%
Return On Assets---0.036-0.034-8%0.008-575%-0.005-85%-0.005-86%
Return On Equity---0.050-0.047-6%0.011-549%-0.007-86%-0.007-86%
Total Gains Per Share----0.0150%0.046-100%-0.0240%0.093-100%
Usd Book Value--1718799000.0001684395500.000+2%1719054250.0000%1710097950.000+1%1774858416.667-3%
Usd Book Value Change Per Share----0%-0%-0%-0%
Usd Book Value Per Share----0%-0%-0%-0%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps----0%-0%-0%-0%
Usd Price Per Share500.500+100%--0%-0%-0%-0%
Usd Profit---86100000.000-79245750.000-8%18982250.000-554%-12138300.000-86%-11975875.000-86%
Usd Revenue---260103000.000-100%467015000.000-100%192460450.000-100%184199750.000-100%
Usd Total Gains Per Share----0%-0%-0%-0%
 EOD+3 -1MRQTTM+10 -8YOY+8 -165Y+12 -710Y+9 -12

3.2. Fundamental Score

Let's check the fundamental score of Opko Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4,491.630
Price to Book Ratio (EOD)Between0-1225.000
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.549
Debt to Asset Ratio (MRQ)Less than10.275
Debt to Equity Ratio (MRQ)Less than10.379
Return on Equity (MRQ)Greater than0.15-0.050
Return on Assets (MRQ)Greater than0.05-0.036
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Opko Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose504.800
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in ILA. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets414,000
Long-term Assets414,000
Total Current Assets
Other Current Assets 233,200
Total Current Assets  (as reported)414,000
Total Current Assets  (calculated)233,200
+/- 180,800
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities267,200
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 49,800
Other Current Liabilities 34,800
Total Current Liabilities  (as reported)267,200
Total Current Liabilities  (calculated)84,600
+/- 182,600
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Net Tangible Assets 860,600



Balance Sheet

Currency in ILA. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
2,766,619
2,760,068
2,768,694
2,721,990
2,584,556
2,578,894
2,530,950
2,480,994
2,451,072
2,575,301
2,456,228
2,369,518
2,309,272
2,232,542
2,323,734
2,371,291
2,473,063
2,519,575
2,421,650
2,417,638
2,399,700
2,306,858
2,369,602
0
02,369,6022,306,8582,399,7002,417,6382,421,6502,519,5752,473,0632,371,2912,323,7342,232,5422,309,2722,369,5182,456,2282,575,3012,451,0722,480,9942,530,9502,578,8942,584,5562,721,9902,768,6942,760,0682,766,619
   > Total Current Assets 
483,601
459,932
472,516
430,556
343,461
349,346
321,562
289,817
317,731
435,237
344,228
292,842
324,045
274,457
360,054
428,109
523,179
599,049
547,029
557,510
823,013
754,069
494,752
414,000
414,000494,752754,069823,013557,510547,029599,049523,179428,109360,054274,457324,045292,842344,228435,237317,731289,817321,562349,346343,461430,556472,516459,932483,601
       Cash And Cash Equivalents 
168,733
131,052
130,530
100,362
91,499
99,943
80,381
43,718
96,473
207,250
111,115
64,667
85,452
34,530
21,612
36,294
72,211
89,503
65,757
148,599
134,700
102,281
210,458
0
0210,458102,281134,700148,59965,75789,50372,21136,29421,61234,53085,45264,667111,115207,25096,47343,71880,38199,94391,499100,362130,530131,052168,733
       Net Receivables 
220,284
238,893
279,679
263,815
187,052
183,981
176,127
181,647
161,983
144,383
148,287
140,765
157,687
146,699
227,148
256,330
302,256
330,293
275,639
265,527
265,588
221,295
175,140
0
0175,140221,295265,588265,527275,639330,293302,256256,330227,148146,699157,687140,765148,287144,383161,983181,647176,127183,981187,052263,815279,679238,893220,284
       Inventory 
47,228
47,492
48,293
46,954
49,333
49,815
46,753
43,379
42,299
44,610
48,293
50,109
61,581
58,697
72,965
111,873
139,600
172,732
134,722
112,861
97,143
99,406
83,306
0
083,30699,40697,143112,861134,722172,732139,600111,87372,96558,69761,58150,10948,29344,61042,29943,37946,75349,81549,33346,95448,29347,49247,228
       Other Current Assets 
47,356
42,495
8,565
12,269
8,207
9,058
10,278
12,135
9,693
4,511
3,234
3,327
15,839
15,786
19,056
7,542
451,000
29,980
33,067
40,858
314,994
316,353
284,300
233,200
233,200284,300316,353314,99440,85833,06729,980451,0007,54219,05615,78615,8393,3273,2344,5119,69312,13510,2789,0588,20712,2698,56542,49547,356
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
2,140,064
2,112,000
2,076,676
1,985,227
1,958,085
1,963,680
1,943,182
1,949,884
1,920,526
1,874,621
1,860,128
1,576,700
1,552,789
1,874,850
0
01,874,8501,552,7891,576,7001,860,1281,874,6211,920,5261,949,8841,943,1821,963,6801,958,0851,985,2272,076,6762,112,0002,140,064000000000
       Property Plant Equipment 
122,831
126,256
133,355
142,437
146,557
148,718
150,156
147,386
144,674
173,242
166,746
164,345
166,491
167,097
169,009
170,587
178,289
177,700
143,001
141,002
123,955
124,667
121,013
0
0121,013124,667123,955141,002143,001177,700178,289170,587169,009167,097166,491164,345166,746173,242144,674147,386150,156148,718146,557142,437133,355126,256122,831
       Goodwill 
704,603
705,990
712,075
715,573
717,099
719,891
714,234
713,629
700,193
698,522
699,842
695,798
671,940
669,582
671,599
675,795
680,602
676,162
677,360
674,574
520,601
519,052
578,845
0
0578,845519,052520,601674,574677,360676,162680,602675,795671,599669,582671,940695,798699,842698,522700,193713,629714,234719,891717,099715,573712,075705,990704,603
       Long Term Investments 
41,139
37,285
30,958
30,176
37,309
36,285
43,698
41,226
30,373
32,297
24,767
11,695
20,746
10,669
26,260
14,325
15,731
10,314
8,877
11,707
10,713
9,457
108,674
0
0108,6749,45710,71311,7078,87710,31415,73114,32526,26010,66920,74611,69524,76732,29730,37341,22643,69836,28537,30930,17630,95837,28541,139
       Intangible Assets 
763,976
746,654
1,377,091
1,362,929
1,331,182
1,314,023
1,294,255
1,277,773
1,250,024
1,232,877
1,216,875
1,199,310
1,119,162
1,103,711
1,089,325
1,076,618
1,065,202
1,046,509
1,035,715
1,024,055
1,110,800
890,498
1,057,409
0
01,057,409890,4981,110,8001,024,0551,035,7151,046,5091,065,2021,076,6181,089,3251,103,7111,119,1621,199,3101,216,8751,232,8771,250,0241,277,7731,294,2551,314,0231,331,1821,362,9291,377,091746,654763,976
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
3,126
3,770
5,528
6,888
7,026
7,487
5,857
10,060
9,745
9,600
8,744
465,900
9,100
8,898
0
08,8989,100465,9008,7449,6009,74510,0605,8577,4877,0266,8885,5283,7703,126000000000
> Total Liabilities 
674,811
653,098
661,865
632,954
699,178
755,630
720,454
692,351
659,781
812,564
747,297
727,589
694,513
683,923
735,391
747,521
801,512
823,061
679,065
652,071
714,600
691,974
650,803
0
0650,803691,974714,600652,071679,065823,061801,512747,521735,391683,923694,513727,589747,297812,564659,781692,351720,454755,630699,178632,954661,865653,098674,811
   > Total Current Liabilities 
263,296
264,951
283,052
258,948
301,335
318,077
306,861
317,830
288,321
396,058
283,374
270,138
249,119
245,087
279,543
335,889
375,483
403,930
303,980
283,035
330,008
309,170
215,472
267,200
267,200215,472309,170330,008283,035303,980403,930375,483335,889279,543245,087249,119270,138283,374396,058288,321317,830306,861318,077301,335258,948283,052264,951263,296
       Short-term Debt 
11,981
11,527
132,466
16,112
11,926
36,715
36,808
37,310
37,413
112,316
11,240
7,187
9,619
0
0
0
0
0
0
0
0
0
0
0
000000000009,6197,18711,240112,31637,41337,31036,80836,71511,92616,112132,46611,52711,981
       Short Long Term Debt 
11,981
11,527
132,466
16,112
11,926
36,715
36,808
37,310
37,413
112,316
11,240
7,187
9,619
12,802
14,463
12,702
24,703
17,816
17,961
14,893
14,695
17,412
18,989
0
018,98917,41214,69514,89317,96117,81624,70312,70214,46312,8029,6197,18711,240112,31637,41337,31036,80836,71511,92616,112132,46611,52711,981
       Accounts payable 
251,315
253,424
62,153
66,536
74,307
64,229
69,061
65,613
47,395
51,085
60,376
77,296
62,537
55,866
44,671
65,685
100,883
162,690
88,512
94,393
82,040
94,240
56,107
49,800
49,80056,10794,24082,04094,39388,512162,690100,88365,68544,67155,86662,53777,29660,37651,08547,39565,61369,06164,22974,30766,53662,153253,424251,315
       Other Current Liabilities 
0
77,556
85,914
59,004
62,548
69,224
67,492
68,346
69,111
67,663
55,775
33,326
60,206
50,477
106,618
123,910
104,585
83,540
65,759
53,685
97,166
79,008
32,342
34,800
34,80032,34279,00897,16653,68565,75983,540104,585123,910106,61850,47760,20633,32655,77567,66369,11168,34667,49269,22462,54859,00485,91477,5560
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
416,506
463,923
457,451
445,394
438,836
455,848
411,632
426,029
419,131
375,085
369,036
412,800
382,804
435,331
0
0435,331382,804412,800369,036375,085419,131426,029411,632455,848438,836445,394457,451463,923416,506000000000
       Capital Lease Obligations Min Short Term Debt
-11,981
-11,527
-132,466
-16,112
-11,926
-36,715
-36,808
-37,310
-37,413
-70,514
26,490
36,360
36,873
46,236
44,452
42,186
44,046
47,492
45,350
42,190
49,902
49,602
50,211
0
050,21149,60249,90242,19045,35047,49244,04642,18644,45246,23636,87336,36026,490-70,514-37,413-37,310-36,808-36,715-11,926-16,112-132,466-11,527-11,981
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
61,154
49,824
49,642
32,532
29,563
31,833
35,532
29,835
20,323
17,785
16,660
48,200
9,616
9,777
0
09,7779,61648,20016,66017,78520,32329,83535,53231,83329,56332,53249,64249,82461,154000000000
       Deferred Long Term Liability 
165,331
159,286
142,212
118,799
148,729
148,732
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000148,732148,729118,799142,212159,286165,331
> Total Stockholder Equity
2,091,808
2,106,970
2,106,829
2,089,036
1,885,378
1,823,264
1,810,496
1,788,643
1,791,291
1,762,737
1,708,931
1,641,929
1,614,759
1,548,619
1,588,343
1,623,770
1,671,551
1,696,514
1,742,585
1,765,567
1,685,100
1,614,884
1,718,799
0
01,718,7991,614,8841,685,1001,765,5671,742,5851,696,5141,671,5511,623,7701,588,3431,548,6191,614,7591,641,9291,708,9311,762,7371,791,2911,788,6431,810,4961,823,2641,885,3782,089,0362,106,8292,106,9702,091,808
   Common Stock
5,586
5,596
5,600
5,600
5,600
5,600
5,602
5,604
5,869
6,162
6,162
6,162
6,704
6,704
6,704
6,706
6,706
6,707
6,898
6,900
6,901
6,902
7,806
1,629,100
1,629,1007,8066,9026,9016,9006,8986,7076,7066,7066,7046,7046,7046,1626,1626,1625,8695,6045,6025,6005,6005,6005,6005,5965,586
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 0-49,171-31,415-30,495-19,923-9,932-13,295-4,225-17,451-25,752-30,187-22,070-28,774-20,351-23,229-20,131-13,138-13,004-539-528-5,422-14,070-24,953-27,009



Balance Sheet

Currency in ILA. All numbers in thousands.




Cash Flow

Currency in ILA. All numbers in thousands.




Income Statement

Currency in ILA. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,774,700
Cost of Revenue-1,193,200
Gross Profit581,500581,500
 
Operating Income (+$)
Gross Profit581,500
Operating Expense-1,789,200
Operating Income-14,500-1,207,700
 
Operating Expense (+$)
Research Development76,800
Selling General Administrative468,900
Selling And Marketing Expenses-
Operating Expense1,789,200545,700
 
Net Interest Income (+$)
Interest Income28
Interest Expense-18,880
Net Interest Income-18,852-18,852
 
Pretax Income (+$)
Operating Income-14,500
Net Interest Income-18,852
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-14,000-15,000
EBIT - interestExpense = -27,141
-14,611
-11,220
Interest Expense18,880
Earnings Before Interest and Taxes (ebit)-8,2614,880
Earnings Before Interest and Taxes (ebitda)35,800
 
After tax Income (+$)
Income Before Tax-14,000
Tax Provision-15,500
Net Income From Continuing Ops-30,100-29,500
Net Income-30,100
Net Income Applicable To Common Shares-30,143
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net50018,852
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
KTSB.MCX
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KTSB.MCX.

KTSB.MCX Daily Candlestick Chart
MGNT.MCX
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MGNT.MCX.

MGNT.MCX Daily Candlestick Chart
SIBN.MCX
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIBN.MCX.

SIBN.MCX Daily Candlestick Chart
FONDIA.HE
3 minutes ago

I found you a Golden Cross on the daily chart of FONDIA.HE.

FONDIA.HE Daily Candlestick Chart
FLXC.SW
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLXC.SW.

FLXC.SW Daily Candlestick Chart
APAM.MC
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of APAM.MC.

APAM.MC Daily Candlestick Chart
PNB.PSE
15 minutes ago

I found you a Golden Cross on the daily chart of PNB.PSE.

PNB.PSE Daily Candlestick Chart
ICT.PSE
16 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of ICT.PSE.

ICT.PSE Daily Candlestick Chart
FGEN.PSE
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FGEN.PSE.

FGEN.PSE Daily Candlestick Chart
DNL.PSE
17 minutes ago

I found you a Golden Cross on the daily chart of DNL.PSE.

DNL.PSE Daily Candlestick Chart
IDC.PSE
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDC.PSE.

IDC.PSE Daily Candlestick Chart
TGODF.OTCQX
20 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of TGODF.OTCQX.

TGODF.OTCQX Daily Candlestick Chart
SBCB.MCX
21 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SBCB.MCX.

SBCB.MCX Daily Candlestick Chart
QZM.V
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of QZM.V.

QZM.V Daily Candlestick Chart
PFLINFOTC.BSE
46 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PFLINFOTC.BSE.

PFLINFOTC.BSE Daily Candlestick Chart
XAUUSD.FOREX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XAUUSD.FOREX.

XAUUSD.FOREX Daily Candlestick Chart
USDNZD.FOREX
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of USDNZD.FOREX.

USDNZD.FOREX Daily Candlestick Chart
USDDKK.FOREX
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of USDDKK.FOREX.

USDDKK.FOREX Daily Candlestick Chart
USDEUR.FOREX
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of USDEUR.FOREX.

USDEUR.FOREX Daily Candlestick Chart
TRYEUR.FOREX
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRYEUR.FOREX.

TRYEUR.FOREX Daily Candlestick Chart
SAREUR.FOREX
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SAREUR.FOREX.

SAREUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
2 hours ago

I found you a Golden Cross on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDINR.FOREX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NZDINR.FOREX.

NZDINR.FOREX Daily Candlestick Chart
NZDTRY.FOREX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NZDTRY.FOREX.

NZDTRY.FOREX Daily Candlestick Chart
NZDSEK.FOREX
2 hours ago

I found you a Golden Cross on the daily chart of NZDSEK.FOREX.

NZDSEK.FOREX Daily Candlestick Chart